IoM Supplement Safety Plan’s Reliance On AER Reviews Problematic – CRN
This article was originally published in The Tan Sheet
Executive Summary
Excessive dependence on adverse event reports to set supplement review priorities under the Institute of Medicine's proposed safety framework could exacerbate the subjectivity of the process, the Council for Responsible Nutrition warned at an IoM public meeting in Washington, D.C. Sept. 26
You may also be interested in...
New Dietary Ingredient Safety Standards Should Be FDA Focus – NNFA
FDA should devote its resources to developing safety guidelines for new dietary ingredient submissions, rather than establishing a safety prioritization system for all supplements, NNFA asserts in recent comments to the Institute of Medicine
New Dietary Ingredient Safety Standards Should Be FDA Focus – NNFA
FDA should devote its resources to developing safety guidelines for new dietary ingredient submissions, rather than establishing a safety prioritization system for all supplements, NNFA asserts in recent comments to the Institute of Medicine
New Dietary Ingredient Safety Standards Should Be FDA Focus – NNFA
FDA should devote its resources to developing safety guidelines for new dietary ingredient submissions, rather than establishing a safety prioritization system for all supplements, NNFA asserts in recent comments to the Institute of Medicine